ArticleScientific reports2026
Remote regulation of hepatic lipid secretion in the intestine by metabolic interaction of dietary arginine with ornithine.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
The quantity and quality of dietary protein profoundly influence satiety, body growth, and systemic metabolism. Among the 20 major proteinogenic amino acids, arginine (Arg) is considerably associated with hepatic steatosis; when animals fed an Arg-deficient diet (ΔArg), triacylglyceride (TAG) dramatically accumulates in the liver. To explore the underlying mechanism, we first investigated the role of ornithine (Orn), as Orn is the primary metabolite of Arg and it is reportedly involved in the regulation of liver metabolism. While male Wistar rats fed a ΔArg diet exhibited a significant increase in liver TAG levels due to an attenuated TAG secretion, and consistently marked reduction of TAG-rich lipoproteins in the circulation, Orn addition to the diet completely abolished all these metabolic changes. Orn was only effective when taken orally, but not through intraperitoneal administration, suggesting that the intestine plays an essential role for Orn to regulate liver metabolism. The metabolic features similar to those of our rat model was also observed in the analyses of clinical samples, implying the common mechanism in humans. Conclusively, dietary Arg deficiency lowers local Arg-to-Orn conversion in the intestine, which in turn inhibits hepatic lipid secretion remotely via gut-liver axis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.